Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Polaryx Therapeutics, Inc. - Common Stock
(NQ:
PLYX
)
2.470
-0.140 (-5.36%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
669,566
Open
2.560
Bid (Size)
2.420 (700)
Ask (Size)
2.470 (200)
Prev. Close
2.610
Today's Range
2.400 - 2.990
52wk Range
2.201 - 48.91
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
What's Going On With Polaryx Therapeutics Stock Wednesday?
↗
February 18, 2026
Polaryx Therapeutics Inc. (NASDAQ: PLYX) stock fell after a surge due to a major clinical development announcement.
Via
Benzinga
Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans
↗
February 17, 2026
Polaryx Therapeutics (NASDAQ: PLYX) shares rise on selecting research organization for SOTERIA trial to evaluate lead candidate for lysosomal storage disorders.
Via
Benzinga
Performance
YTD
-92.9%
-92.9%
1 Month
-92.9%
-92.9%
3 Month
-92.9%
-92.9%
6 Month
-92.9%
-92.9%
1 Year
-92.9%
-92.9%
More News
Read More
Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial
February 17, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™
February 10, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx Therapeutics Welcomes New Members of the Board of Directors
February 05, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch
February 03, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Polaryx Therapeutics, Inc. - Common Stock publicly traded?
Yes, Polaryx Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Polaryx Therapeutics, Inc. - Common Stock trade on?
Polaryx Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Polaryx Therapeutics, Inc. - Common Stock?
The ticker symbol for Polaryx Therapeutics, Inc. - Common Stock is PLYX on the Nasdaq Stock Market
What is the current price of Polaryx Therapeutics, Inc. - Common Stock?
The current price of Polaryx Therapeutics, Inc. - Common Stock is 2.470
When was Polaryx Therapeutics, Inc. - Common Stock last traded?
The last trade of Polaryx Therapeutics, Inc. - Common Stock was at 02/23/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.